Cost-effectiveness analysis of a large jail-based methadone maintenance treatment continuation program in New Mexico

被引:6
|
作者
Horn, Brady P. [1 ,2 ]
Li, Xiaoxue [1 ]
McCrady, Barbara [2 ,3 ]
Guerin, Paul [4 ]
French, Michael T. [5 ]
机构
[1] Univ New Mexico, Dept Econ, MSC 05 3060,1 Univ New Mexico, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Ctr Alcoholism Subst Abuse & Addict CASAA, 2650 Yale SE MSC11-6280, Albuquerque, NM 87106 USA
[3] Univ New Mexico, Dept Psychol, MSC 05 3060,1 Univ New Mexico, Albuquerque, NM 87131 USA
[4] Univ New Mexico, Inst Social Res, 1915 Las Lomas, Albuquerque, NM 87131 USA
[5] Univ Miami, Miami Herbert Business Sch, Dept Hlth Management & Policy, Coral Gables, FL 33124 USA
关键词
Opioid use disorder; Methadone maintenance; Cost-effectiveness analysis; Jail; Recidivism; SUBSTANCE-ABUSE TREATMENT; ECONOMIC-EVALUATION; DRUG-ABUSE; PRISON; ADDICTION; COMMUNITY; COURT;
D O I
10.1016/j.jsat.2020.108042
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The U.S. has the second-highest incarceration rate in the world and spends more than $80 billion annually to house inmates. The clinical research literature suggests that methadone maintenance treatment (MMT) is an effective method to treat opioid use disorders (OUD) and that jails are a potentially valuable environment to implement MMT. Currently, jail-based MMT is rarely implemented in practice, due in part to resource limitations and other economic considerations. The primary goal of this study was to perform a cost-effectiveness analysis (CEA) of jail-based MMT using data from a unique MMT continuation program located in a large urban jail in New Mexico. Recidivism data were collected for a three-year period both before and after incarceration, and quasi-control groups were constructed from both substance-using and general populations within the jail. Base models show that inmates enrolled in jail-based MMT exhibited significantly fewer days of incarceration due to recidivism (29.33) than a group of inmates with OUDs who did not receive MMT. Economic estimates indicate that it cost significantly less ($23.49) to reduce an incarcerated day using jail-based MMT than incarceration per se ($116.49). To mitigate potential sample selection bias, we used both propensity-score-matching and difference-in-differences estimators, which provided comparable estimates when using the OUD non-MMT comparison group. Difference-in-differences models find that, on average, MMT reduced recidivism by 24.80 days and it cost $27.78 to reduce an incarcerated day using jail-based MMT. Assuming a willingness to pay threshold of the break-even cost of reducing one incarcerated day, we estimate a 93.3% probability that this MMT program is cost-effective. Results were not as strong or consistent when using other comparison groups (e.g., alcohol-detoxified and general-population inmates). Overall, results suggest that it costs substantially less to provide jail-based MMT than incarceration alone. Jail administrators and policymakers should consider incorporating MMT in other jail systems and settings.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS ANALYSIS OF CLOFARABINE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA IN MEXICO
    Rely, K.
    Salinas, E. G.
    Pierre, K. A.
    Dorantes, M. E. A.
    VALUE IN HEALTH, 2009, 12 (07) : A496 - A496
  • [32] A cost-effectiveness analysis model for treatment of candidiasis and invasive aspergillosis in Mexico
    Quevedo, JFM
    Contreras, I
    Garcia-Contreras, F
    Nevarez, A
    Constantino-Casas, P
    Garduño, J
    VALUE IN HEALTH, 2005, 8 (03) : 308 - 308
  • [33] A COST-EFFECTIVENESS ANALYSIS OF EXTENDING METHADONE AND BUPRENORPHINE-NALOXONE MAINTENANCE TREATMENT OF OPIOID DEPENDENCE FROM EIGHT TO SIXTEEN MONTHS
    Russell, C.
    McKeganey, N.
    VALUE IN HEALTH, 2013, 16 (03) : A61 - A61
  • [34] A cost-effectiveness and cost-benefit analysis of contingency contracting-enhanced methadone detoxification treatment
    Hartz, DT
    Meek, P
    Piotrowski, NA
    Tusel, DJ
    Henke, CJ
    Delucchi, K
    Sees, K
    Hall, SM
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 1999, 25 (02): : 207 - 218
  • [35] COST-EFFECTIVENESS ANALYSIS OF A MULTIDISCIPLINARY SUPPORT PROGRAM IN HEPATITIS C TREATMENT
    Garcia-Retortillo, Montserrat
    Cirera, Isabel
    Dolors Gimenez, M.
    Marquez, Carmen
    Canete, Nuria
    Carrion, Jose A.
    Castellvi, Pere
    Lazaro, Diego
    Navines, Ricard
    Castano, Juan R.
    Urbina, Olatz
    Salas, Esther
    Bory, Felip
    Martin-Santos, Rocio
    Rubio-Terres, Carlos
    Martin-Escudero, Victoria
    Sola, Ricard
    HEPATOLOGY, 2011, 54 : 800A - 801A
  • [36] Office-Based Buprenorphine Versus Clinic-Based Methadone: A Cost-Effectiveness Analysis
    King, Jordan B.
    Sainski-Nguyen, Amy M.
    Bellows, Brandon K.
    JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, 2016, 30 (01) : 55 - 65
  • [37] A COST-EFFECTIVENESS ANALYSIS OF DETOXIFICATION AND MAINTENANCE TREATMENT WITH BUPRENORPHINE/NALOXONE COMBINATION IN TURKEY
    Hren, R.
    VALUE IN HEALTH, 2016, 19 (07) : A525 - A525
  • [38] Cost-effectiveness analysis of dopamine agonists for the treatment of infertility asociated to hyperprolactinemia in Mexico
    Guillen-Gonzalez, S.
    Diez-Canseco, F.
    Zapata, L.
    Vega-Hernandez, G. Y.
    Rivas, R.
    Ramirez, H.
    Mould-Quevedo, J.
    Davila-Loaiza, G.
    VALUE IN HEALTH, 2008, 11 (03) : A226 - A226
  • [39] A Uk Based Cost-Effectiveness Analysis Of Glycopyrronium Bromide A New Anti-Muscarinic Agent For The Maintenance Treatment Of Patients With COPD
    Malcolm, W. A.
    Keyzor, I.
    Radwan, A.
    Price, D. B.
    Asukai, Y.
    Ananthapavan, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [40] A cost-effectiveness analysis of a school-based obesity prevention program
    Wang, L
    Yin, Z
    Gutin, B
    Hanes, J
    Cavnar, M
    Moore, J
    Johnson, M
    Barbeau, P
    Thornburg, J
    OBESITY RESEARCH, 2004, 12 : A18 - A18